Member Info for lambo222

Over £1m traded in the last week…. That’s huge for a tiny company like IMM, will continue to build this week ahead of company making announcement on 29th, think we will be 8-10p Friday morning easily

Huge buys coming in now, could be some huge money to be made here over the next week

CEO predicts $150m a year in royalties from the US alone… the billionaire investors who back Avion could well make an investment in IMM once we get FDA approval… 4 trading days left until news, FDA will be having their meetings early this week imo with meeting minutes typed up end of week and sent to Avion and IMM on 29th August via written response, could be a big story about to unfold here imo 15-20p daily possible on approval imo

Only 4 trading days to go before FDA decision… Monday is bank holiday so news Tuesday imo could be blockbuster it’s been a while since sim had a 200% riser, think this did 300% when they first announced the Avion deal

Will be 8p by the end of this week imo as people begin to take positions, many people forget this company was £250m Mcap and well over £100m Mcap for the majority of the last phase 3 trial, Avion want to see Lupozor as their lead product in the US… Avion is owned by billionaire US investors… if they start to take a position in little old IMM once we get FDA approval the rise here will be something very special indeed, won’t take much to push this up to £100m Mcap a 5 bagger from current levels and it would still look cheap as we do partnering deals for rest of world rights and also the phase 3 in CIDP trial, exciting times ahead

Big week ahead, defining few days in the history of this company, think this explodes on FDA approval as many are waiting in the sidelines, high risk high reward but think this does 200% on approval, GL all we are in for quite a ride over the next few days, 20p possible intraday imo

There’s not even close to £1m to flip either, there was £950k placing, £100k went to bod, friend of mine took £50k so that’s only £800k, a lot of that will have been long term holders reducing their averages, I know you took a few Dallo? £700k volume this week which is huge for IMM so I reckon we will have shaken off the loose hands by early next week! And a lot of people will wait for the FDA decision on the 29th, 5 trading days to go, I personally think we see this move towards 7p next week ahead of news, positive and it’s 15p all day long imo

Yep your right Maestro the drug was a big success on those patients with bio markers and this time around only patients with the bio marker will take part in the trial! If we get the FDA approval we could be onto something very special here, tiny Mcap and billion $ sales potential annually, CEO predicts profits of $150m from royalties annually, can you imagine the Mcap if we get to them levels and that’s just US sales alone! Next week I full expect this to push towards 8p ahead of news

They are in advanced discussions regarding partnering discussions for the CIDP trial, I’m assuming one of these companies is Avion as it would make total sense for them to run the CIPD trial too and it fits with their MO, all will be revealed after the FDA decision, it unlocks everything for IMM after 3 years of inactivity, FDA approval sparks this back into life, exciting week next week as people take their positions, bank holiday on the 29th so we should get the rns next Tuesday

Well hopefully it follows the same pattern as AZN Approved Lupus drug, passed the second phase 3 trial, gained FDA approval and all in a short space of time,life changing gains on offer here for those of us in early sub 6p could easily be worth 60p if we get FDA approval and another partner deal for the ROW rights, then we have CIDP trial and all the other indications for a Lupozor, think we will have a big week here next week as people start to take positions… only 5 trading days left to get in before news after today, GL all

More buys than sells! Only two 200k trades from what I can see, next week the real move will start ahead of FDA decision

Hmmm but the US rights come with £70m to IMM and double digit royalties, like I say FDA decision unlocks everything

It wasn’t fully funded last time, it was funded by Lanstead in the main part and over £20m was sold into the market to pay for it, this time we don’t need £20m to pay for the trial because Lanstead are paying $25m for it, having Avion on board opens many doors, they have received 3 FDA approvals for their drugs, they have a big marketing department and know how to market and sell a drug, we received £70m in milestone payments and double digit royalties estimated to be $150m by our CEO annually, and we still own the rest of the world rights to Lupozor and can negotiate some juicy deals once FDA approval is hopefully given on 29 August! Mcap is £17m it’s ridiculously undervalued by any metric and totally off the radar… this will change if we get approval, not long to wait

If this gets back to £250m Mcap as it did during the last phase 3 trial I don’t think we need to worry about warrants

I think your a bit wet in the head tbh mate! Hopefully the FDA decision comes in good on 29th August and you can stop the whining

How many times Wigwammer, warrants are good for companies in the main, if they ever get converted the cash goes straight to the balance sheet, so the company would be cash rich, have a fully funded phase 3 trial for $25m, receive £70m in payments once fully approved by the FDA and milestones hit, and if the company and Avion hit their targets receive $150m annually from the US market alone from sales of Lupozor, the potential here is staggering, and over the last few days it looks like we have a very hungry buying, lots of 100,000 trades throughout yesterday and today with over £500,000 traded, can you imagine the volume if we get FDA approval!

It’s all down to the FDA, any warrants that are converted the cash goes straight to the balance sheet in any case which is good for the company, it’s not as though the warrants are at 1p! 29th August is a bank holiday in the UK so the last date for anyone to take a position ahead of news will be 26th August… less than 10 days away, if positive it’s 15-20p all day long and fully expect a run up to 8p in anticipation, over £500k traded in the last two days shows you the interest is huge and if we get some US buyers who want exposure to Lupozor then the rise could be truly epic

The upcoming FDA decision unlocks everything for IMM, it unlocks $25m funding for a phase 3 trial for a drug with multi billion $ potential revenues, it unlocks partnering discussions for ROW rights, and it unlocks significant value for shareholders, not many companies on aim with the potential this has, CEO stated revenues of $100-150m annually a realistic target in the future… and that’s just in the US! current Mcap £17….

They have already jumped through the hoops for the last 3 years!! I am very confident they will get approval, not long to wait only 7 trading days to go before the FDA provide their written response

The rise has barley begun! FDA approval decision due on 29th August, if positive we should see 15-20p here imo